ProBioGen and Merus Sign Deal on GlymaxX® ADCC Enhancement Technology

News   Mar 05, 2014

 
ProBioGen and Merus Sign Deal on GlymaxX® ADCC Enhancement Technology
 
 
 

RELATED ARTICLES

Sheep Toxin Could Cause MS

News

Exposure to a toxin primarily found in sheep could be linked to the development of multiple sclerosis (MS) in humans, new research suggests.

READ MORE

New Microscope Captures Detailed 3-D Movies of Cells Deep Within Living Systems

News

Merging lattice light sheet microscopy with adaptive optics reveals the most detailed picture yet of subcellular dynamics in multicellular organisms.

READ MORE

How Environmental Pollutants and Genetics Work Together in Rheumatoid Arthritis

News

It is well known that individuals with a particular version of human leukocyte antigen have an increased risk for rheumatoid arthritis, but there has been growing interest in the role of environmental pollutants. In a new mouse study, researchers probed the relationship between the two.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Biopharma

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE